PQQ OCT Glutathione Vitamin K2 Coenzyme Q10 Vegan Vitamin D3 Creatine monohydrate L-methylfolate DTF powder and Film Microencapsulated Vitamins
Dyestuff Nutrition Pharmaceutical DTF Powder and DTF Film
Nutrition news Dyestuff news Vitamins Knowledge L-Methylfolate Knowledge
Release time：2026-03-14 Click:
Home >News >Nutrition news
Pyrroloquinoline Quinone (PQQ) is a novel redox cofactor that has garnered significant attention for its multifaceted role in cellular health and disease prevention. Unlike typical antioxidants that are consumed in a single reaction, PQQ is a redox-cycling molecule, meaning it can perform thousands of electron transfers. This unique capability underpins its powerful effects on nerve cells, heart tissue, and mitochondrial function. Below, we explore the primary applications of PQQ, supported by scientific insights.
Oxidative stress, an imbalance between free radicals and the body's ability to neutralize them, is a root cause of numerous chronic conditions. PQQ stands out due to its catalytic antioxidant properties. Studies indicate that PQQ is up to 100 times more effective at stimulating mitochondrial biogenesis than other common supplements like resveratrol. This section delves into how PQQ combats oxidative damage across different biological systems.
The neuroprotective prowess of PQQ is closely linked to its interaction with the N-methyl-D-aspartate (NMDA) receptor. By oxidizing the redox regulatory site of this receptor, PQQ acts as a potent antagonist against NMDA and glutamate-mediated neuronal cell death. Research involving models of stroke has shown that PQQ treatment can reduce the volume of damaged brain tissue by up to 40% , highlighting its potential in mitigating acute neurological injuries.
For the cardiovascular system, the most significant threat often comes from reperfusion injury—the damage caused when blood supply returns to tissue after a period of ischemia. This process generates a storm of reactive oxygen species (ROS). PQQ effectively scavenges these ROS. In isolated heart models, PQQ supplementation has been demonstrated to reduce the release of lactate dehydrogenase (a marker of heart cell death) by nearly 50% , preserving myocardial integrity and function.
Cataract formation is directly correlated with the oxidation of lens proteins. PQQ intervenes by dramatically elevating the levels of reduced glutathione (GSH)—the eye's primary endogenous antioxidant. By increasing GSH concentrations in the lens by over 30% in preclinical models, PQQ helps maintain lens transparency, prevents protein denaturation, and alleviates the progression of cataract symptoms.
The liver is highly susceptible to oxidative injury. PQQ provides potent hepatoprotection by boosting hepatic glutathione reserves, which in turn inhibits lipid peroxidation—a process where free radicals degrade lipids, damaging cell membranes. Furthermore, PQQ facilitates the clearance of biliverdin, reducing its cytotoxic retention time in liver tissues. Studies confirm that PQQ significantly lowers serum markers of liver damage, such as GPT, without altering normal baseline indicators like blood glucose, demonstrating its targeted safety.
By neutralizing ROS induced by hepatotoxic substances, PQQ prevents the cascade of events leading to liver cell necrosis. This protective effect ensures that routine liver function remains uncompromised while pathological damage is actively reduced.
Beyond its antioxidant capacity, PQQ functions as a growth factor mimetic, activating critical pathways for cell proliferation and longevity.PQQ uniquely induces the activation of the Epidermal Growth Factor Receptor (EGFR) independently of its natural ligand. This triggers downstream signaling, leading to increased proliferation in epithelial cell lines. The mechanism involves PQQ's redox cycling, which produces transient hydrogen peroxide (H₂O₂). This, in turn, oxidizes and inactivates Protein Tyrosine Phosphatase 1B (PTP1B)—an enzyme that normally "turns off" the EGFR signal. By inhibiting PTP1B, PQQ sustains the growth signal, promoting healthy tissue regeneration and repair.
The systemic antioxidant and signaling effects of PQQ translate into tangible benefits for preventing and managing a wide range of age-related and chronic diseases.
In models of osteoarthritis induced by anterior cruciate ligament transection (ACLT), PQQ administration has been shown to halt disease progression. By inhibiting oxidative stress and subsequent DNA damage within chondrocytes (cartilage cells), PQQ treatment results in a significantly lower Osteoarthritis Research Society International (OARSI) score compared to untreated controls, indicating preserved cartilage integrity.
PQQ exerts anti-osteoporotic effects by upregulating the body's total antioxidant capacity. It reduces oxidative damage to bone cells, downregulates cyclin-dependent kinase inhibitors (CDKIs), and decreases apoptosis (cell death). This multifaceted action helps maintain a healthy balance between bone resorption and formation, leading to improved bone mineral density.
Perhaps PQQ's most celebrated role is in mitochondrial biogenesis. Neurons, which can contain millions of mitochondria, are particularly dependent on this. PQQ not only directly scavenges free radicals within these "powerhouses" but also activates pathways that lead to the creation of new, healthy mitochondria. Clinical studies show that supplementation with just 20 mg of PQQ can improve mitochondrial efficiency, leading to better sleep quality and reduced fatigue within 8 weeks.
Oxidative stress is a leading cause of male infertility, with studies showing that up to 40% of men with idiopathic asthenozoospermia have elevated ROS levels in their seminal plasma. High ROS damages the sperm membrane and depletes ATP, crippling motility. PQQ works synergistically with endogenous antioxidants (SOD, CAT, GSH) to neutralize this ROS, thereby protecting the structural integrity and energy supply necessary for normal sperm function and fertilization capacity.
In gynecological health, PQQ demonstrates efficacy in reducing endometrial damage. By effectively scavenging oxygen free radicals in the endometrium, it inhibits the proliferation of endometrial stromal cells. In vivo studies have shown that PQQ, especially in synergy with other antioxidants like NAC, can significantly reduce the size of endometriotic lesions, decreasing glandular infiltration without the side effects that hinder fertility.
PQQ offers a dual-layer defense against Parkinson's disease. First, it directly protects neuronal cells from oxidative insults. Second, it modulates the expression and oxidative state of DJ-1, a protein whose dysfunction is linked to familial Parkinson's. By stabilizing DJ-1, PQQ effectively prevents the neuronal death pathway triggered by sustained oxidative stress, offering a potential strategy for neuroprotection.
Looking for a reliable partner for your PQQ supply? LeadingChem is a professional PQQ manufacturer dedicated to providing the highest quality Pyrroloquinoline Quinone for your innovative health products.
→Email: info@leadingchemical.com←
Whatsapp:+8615669938129
More detail: https://www.leadingchemical.com/gb2312/PQQ/
